Politiparty
Politiparty

119th Congress Health

S. 2121: SUPPORT for Patients and Communities Reauthorization Act of 2025

Introduced

  1. Introduced (completed)Jun 18, 2025
  2. Passed Senate (not reached)
  3. Passed House (not reached)
  4. To the President (not reached)
  5. Became law (not reached)

Summary

Introduced in Senate, Jun 18, 2025

This bill reauthorizes and revises Department of Health and Human Services (HHS) programs that address substance use disorders, overdoses, and mental health.

For example, the bill reauthorizes for FY2026-FY2030 grant and other programs relating to

• addressing substance use disorders with respect to pregnant and postpartum women,

Read the full summary

• prevention and recovery from substance use disorders for youth,

• housing for individuals in recovery from substance use disorders,

• community organizations facilitating recovery from substance use disorders,

• loan repayment for certain health care providers treating substance use disorders,

• prevention of overdoses of controlled substances,

• treatment of children experiencing psychological trauma, and

• mental and behavioral health education and training for medical and allied health students.

Also, the bill revises several programs, including by (1) expanding a program that supports resources for first responders to include the purchase of drugs or devices to treat non-opioid overdoses, (2) expanding a program that supports employment services for individuals in recovery so as to allow for the provision of related transportation services, and (3) temporarily authorizing a regional technical assistance center to assist the National Peer-Run Training and Technical Assistance Center for Addiction Recovery Support.

Additionally, the bill establishes new requirements for HHS, including requirements relating to

• protecting the National Suicide Prevention Lifeline program from cybersecurity threats,

• establishing a Federal Interagency Work Group on Fentanyl Contamination of Illegal Drugs, and

• reviewing and potentially revising the scheduling of approved products containing a combination of buprenorphine and naloxone under the Controlled Substances Act.

Written by the Congressional Research Service, Library of Congress.

Roll calls

0 votes on this bill

No roll call votes have been held on this bill.

Amendments

0 offered

No amendments were offered to this bill.

Cosponsors

8

Bipartisan support.

Who scored on this bill

6 points earned
  1. 1Bill Cassidy R-LA SponsorDrew cross-party cosponsors, introduced2 events+6
See all scorers and every scoring event

Introductions and cosponsorships count toward weekly caps and show no points.

Other bills by Bill Cassidy

History

  1. Jun 18, 2025Introduced in the Senate by Bill Cassidy.
Show the full action history (2 actions)
  1. Jun 18, 2025Introduced in Senate
  2. Jun 18, 2025Read twice and referred to the Committee on Health, Education, Labor, and Pensions.